Thumbnail

アジア太平洋地域のビグアニド市場–医薬品、および地理学でセグメント化–成長、傾向、および予測(2020-2025)

Looking to buy the report?

1. Introduction

               1.1 Scope of Study

               1.2 Market Definition

               1.3 Executive Summary

2. Research Methodology

               2.1 Study Deliverables

               2.2 Study Assumptions

               2.3 Research Phases

3. Market Insights

               3.1 Technology Trends

               3.2 Industry Attractiveness - Porter's Five Forces Analysis

                              3.2.1 Bargaining Power of the Suppliers

                              3.2.2 Bargaining Power of the Consumers

                              3.2.3 Threat of New Entrants

                              3.2.4 Threat of Substitute Products and Services

                              3.2.5 Competitive Rivalry within the Industry

4.  Market Dynamics

               4.1 Drivers

               4.2 Restraints

               4.3 Opportunities

5. Market Indicators

               5.1 Total Diabetes Population

               5.2 Type 2 Diabetes Population

6. Market Segmentation and Analysis

               6.1 By Drug

                              6.1.1 Metformin

                                             6.1.1.1 Metformin, Revenue (2012-2023)

                                             6.1.1.2 Metformin, Volume (2012-2023)

7. Geographical Analysis

               7.1 Asia pacific

                              7.1.1 Australia

                                             7.1.1.1 Australia, Revenue (2012-2023)

                                             7.1.1.2 Australia, Volume (2012-2023)

                              7.1.2 India

                                             7.1.2.1 India, Revenue (2012-2023)

                                             7.1.2.2 India, Volume (2012-2023)

                              7.1.3 Indonesia

                                             7.1.3.1 Indonesia, Revenue (2012-2023)

                                             7.1.3.2 Indonesia, Volume (2012-2023)

                              7.1.4 Thailand

                                             7.1.4.1 Thailand, Revenue (2012-2023)

                                             7.1.4.2 Thailand, Volume (2012-2023)

                              7.1.5 Philippines

                                             7.1.5.1 Philippines, Revenue (2012-2023)

                                             7.1.5.2 Philippines, Volume (2012-2023)

                              7.1.6 Vietnam

                                             7.1.6.1 Vietnam, Revenue (2012-2023)

                                             7.1.6.2 Vietnam, Volume (2012-2023)

                              7.1.7 China

                                             7.1.7.1 China, Revenue (2012-2023)

                                             7.1.7.2 China, Volume (2012-2023)

                              7.1.8 South Korea

                                             7.1.8.1 South Korea, Revenue (2012-2023)

                                             7.1.8.2 South Korea, Volume (2012-2023)

                              7.1.9 Japan

                                             7.1.9.1 Japan, Revenue (2012-2023)

                                             7.1.9.2 Japan, Volume (2012-2023)

                              7.1.10 Malaysia

                                             7.1.10.1 Malaysia, Revenue (2012-2023)

                                             7.1.10.2 Malaysia, Volume (2012-2023)

                              7.1.11 Rest of Asia Pacific

                                             7.1.11.1 Rest of Asia Pacific, Revenue (2012-2023)

                                             7.1.11.2 Rest of Asia Pacific, Volume (2012-2023)

8. Key Player Profiles

               8.1 Dr Reddy's

               8.2 Lupin

               8.3 Teva

               8.4 Takeda

               8.5 Ranbaxy/Sun Pharma

               8.6 Bayer

               8.7 Mylan

               8.8 Merck

               8.9 Bristol-Myers Squibb

               8.10 Boehringer Ingelheim Pharmaceuticals

* Each Company Profile include overview, Revenue, Product and services, Swot, Recent Activities and strategic Analysis.

 

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?

Email

Message

By submitting, you confirm that you agree to our privacy policy